Replies to post #87832 on Anavex Life Sciences Corp (AVXL)

[Rubyred77]

Hmm. Doesn't look promising. So we will get readouts of p3 trial companies that still attack plaques.
CEO of Lilly said it's still a step forward for science, but what he should have said was that they will step ASIDE and let a risk taking company that won't target plaques have some mic time.
GLTA